InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（15 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
15
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Dulac Edward J III, 首席财务官. Insider active across 2 companies, notably Fate Therapeutics INC. Cumulatively, 22 reports have been recorded. Split: 0 buy · 15 sells. Total volume traded: €783k. Activity tracked since 19 August 2021. The latest transaction was disclosed on 22 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Dulac Edward J III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
8,111 股@ US$11.250.0059% mcap27.3% 占其流量Common StockSEC:0001193125-26-316279:0
4,677 股@ US$18.000.0053% mcap100.0% 占其流量Common StockSEC:0001821530-26-000002:0
61,280 股0Common StockSEC:0001193125-26-088254:0
6,379 股@ US$9.2123.6% 占其流量Common StockSEC:0001193125-26-006275:0
7,462 股@ US$14.0254.7% 占其流量Common StockSEC:0000950170-25-098774:0
47,200 股0Common StockSEC:0000950170-25-032192:0
66,324 股0Common StockSEC:0000950170-24-086061:0
2,447 股@ US$7.770.7% 占其流量Common StockSEC:0000950170-24-025992:0
1,849 股@ US$5.000.3% 占其流量Common StockSEC:0000950170-24-008803:0
7,028 股@ US$4.371.1% 占其流量Common StockSEC:0000950170-24-003647:0
5,182 股@ US$3.660.6% 占其流量Common StockSEC:0000950170-24-000874:0
1,585 股@ US$3.500.2% 占其流量Common StockSEC:0001209191-23-059103:0
4,718 股@ US$2.800.5% 占其流量Common StockSEC:0001209191-23-046691:0
5,182 股@ US$4.830.9% 占其流量Common StockSEC:0001209191-23-041607:0
7,331 股@ US$5.241.3% 占其流量Common StockSEC:0001209191-23-002975:0
4,703 股@ US$29.755.2% 占其流量Common StockSEC:0001209191-22-046929:0
33,302 股0Common StockSEC:0000899243-22-003443:0
1,380 股@ US$48.254.0% 占其流量Common StockSEC:0001209191-22-003168:0
14,437 股@ US$35.5231.0% 占其流量Common StockSEC:0001209191-21-070768:0
59,540 股0Common StockSEC:0001209191-21-066159:0
17,325 股@ US$35.5235.7% 占其流量Common StockSEC:0001209191-21-058176:0
1,937 股@ US$87.909.9% 占其流量Common StockSEC:0001209191-21-052742:0
22 条申报中的 22 条
About Dulac Edward J III
Dulac Edward J III is Directeur Financier. He has 21 filings in total, and in the recent filings available, all are sales, for a total of EUR 703367 between 2021-08-20 and 2026-07-06. His listed companies are Fate Therapeutics INC and Intellia Therapeutics, Inc.
